Chemodex

Apigenin 7-glucoside

CHF 54.00
In stock
CDX-A0568-M0055 mgCHF 54.00
CDX-A0568-M01010 mgCHF 95.00
CDX-A0568-M02525 mgCHF 189.00
More Information
Product Details
Synonyms Apigetrin; Cosmosiin; 4',5,7-Trihydroxyflavone 7-glucoside; 7-O-β-D-Glucopyranosylapigenin; Apigenin-7-O-β-D-glucoside; NSC 407303
Product Type Chemical
Properties
Formula

C21H20O10

MW 432.38
CAS 578-74-5
Source/Host Chemicals Plant
Purity Chemicals ≥97% (HPLC)
Appearance Light yellow powder.
Solubility Soluble in DMSO (5mg/ml) or DMF.
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key KMOUJOKENFFTPU-QNDFHXLGSA-N
Smiles O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](OC2=CC(OC(C3=CC=C(O)C=C3)=CC4=O)=C4C(O)=C2)[C@@H]1O
Shipping and Handling
Shipping AMBIENT
Short Term Storage -20°C
Long Term Storage -20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Apigenin 7-glucoside is a flavonoid with anti-inflammatory, antioxidant, anticancer, anti-adipogenic and anxiolytic activities. It has been shown to inhibit LPS-induced nitric oxide production in RAW 264.7 cells or have hepatoprotective activity due to it's antioxidant activities, acting as scavengers of ROS. Apigenin 7-glucoside has been shown to have anti-proliferative activity, possible through cell cycle inhibition and consequently induce apoptosis. it also has the ability to enhance melanogenesis synthesis and tyrosinase activity of B16F10 melanoma cells. Apigenin 7-glucoside has shown neuroprotective effects possibly by inhibiting neuroinflammation and its antioxidant activity. Apigenin-7-O-glucoside inhibits adipogenesis of 3T3-L1 preadipocytes at early stage of adipogenesis at high concentrations, by downregulating PPARγ and CEBP-α.

Product References

(1) J. Fuchs & R. Milbradt; Arzneimittelforschung 43, 370 (1993) | (2) Q.S. Zheng, et al.; Biomed. Environ. Sci. 18, 65 (2005) | (3) E. Nakazaki, et al.; Eur. J. Nutr. 52, 25 (2013) | (4) D. Kumar & Z.A. Bhat; Phytomedicine 21, 1010 (2014) | (5) N. Nasr Bouzaiene, et al.; Life Sci. 144, 80 (2016) | (6) H.S. Lim, et al.; J. Med. Food 19, 1032 (2016) | (7) Q. Sun, et al.; BBRC 498, 164 (2018) | (8) F. Hadrich & S. Sayadi; Lipids Health Dis. 17, 95 (2018) | (9) H. Guo, et al.; Biomed. Pharmacother. 109, 1978 (2019)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.